Connect with us
UTRECHT, Netherlands, April 01, 2019 — Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length human bispecific...
AUSTIN, Texas, April 01, 2019 — Following Talroo’s success with other industry verticals like Healthcare, Restaurant, Retail, Financial Services, and more, Talroo today announced the launch...
NEW YORK, April 01, 2019 — In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,...
Portland, April 01, 2019 — Acknowledging the increasing criticality of automating discrete tasks in an end-to-end process, iGrafx becomes the first reseller of Servicetrace Robotic Solutions...
LAUSANNE, Switzerland, April 01, 2019 — AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced...
BOSTON, April 01, 2019 — Ziopharm Oncology, Inc. (Nasdaq: ZIOP), a clinical stage immuno-oncology company developing next generation cell and gene therapies, today announced that the...
SASKATOON, Saskatchewan, April 01, 2019 — UEX Corporation (UEX:TSX) (“UEX” or the “Company”) is pleased to announce the third tranche of assay results have been received...
RESEARCH TRIANGLE PARK, N.C., April 01, 2019 — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present at the H.C. Wainwright Global Life Sciences...
KITCHENER, Ontario, April 01, 2019 — James E. Wagner Cultivation Corporation (“JWC” or the “Corporation”) (TSX VENTURE: JWCA; OTCQX: JWCAF), is pleased to announce that it...
Fairfax VA, April 01, 2019 — Visium Technologies, Inc. (OTCPink: VISM) (“Visium” or the “Company”) announced today that it has entered into a technology license agreement...
ZUG, Switzerland and CAMBRIDGE, Mass., April 01, 2019 — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today...
BRIDGEWATER, N.J., April 01, 2019 — Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
CAMBRIDGE, Mass., April 01, 2019 — Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced the appointment of Wendy...
MONTREAL, April 01, 2019 — Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that top-line results, from a study funded by the National Institutes of Health led...
Distinguished Entrepreneur and Developer of a Growing Revolution in Healthcare Brings Global Vision and Experience to the Tree of Knowledge Board TORONTO, ON , April 01,...
OTTAWA, April 01, 2019 — Hobo Recreational Cannabis Store (“Hobo”), the new cannabis venture from hospitality company, Donnelly Group, today announces the opening and launch of...
WOBURN, Mass., April 01, 2019 — Replimune Group Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, today announced that...
DUBLIN, Ireland, April 01, 2019 — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections,...
LEIDEN, Netherlands and CAMBRIDGE, Mass., April 01, 2019 — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines...
Highlights Interpretation of the conventional and BMR wireline log data indicates: Interval between 404 and 464 metres has approximately 18 metres of net coal with 12...